Neuraminidase as a novel therapeutic management strategy for Alzheimer’s disease: evidenced through molecular docking, molecular dynamic simulation and gene expression analysis

Neuraminidase as a novel therapeutic management strategy for Alzheimer’s disease: evidenced through molecular docking, molecular dynamic simulation and gene expression analysis

IntroductionNeuraminidase in humans is studied to see how well repurposed oseltamivir works for treating Alzheimer’s disease (AD) using methods like molecular docking, molecular dynamic (MD) simulation, and gene expression analysis. Gene enrichment analysis was also studied to understand the behavio...

Full description

Saved in:
Bibliographic Details
Main Authors: Sami I. Alzarea, Omar Awad Alsaidan, Hassan H. Alhassan, Abdulaziz Ibrahim Alzarea, Tariq G. Alsahli, Metab Alharbi, Muhammad Afzal, Mohammad Jaffar Sadiq Mantargi
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-05-01
Series:Frontiers in Chemistry
Subjects:
Alzheimer’s disease
oseltamivir
neuraminidase
molecular docking
molecular dynamic simulation
gene expression analysis
Online Access:https://www.frontiersin.org/articles/10.3389/fchem.2025.1574702/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fchem.2025.1574702/full

Similar Items